티움바이오
321550KOSDAQ· 연구개발업4,480원-115 (-2.50%)전일 종가 2026-09-18
52주 위치
3,41513,70010%신고가 대비 -67.30%
- 시가총액
- 1,450억
- PBR
- 4.02
- EPS(TTM)
- -596원
- BPS
- 1,115원
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | -36.83% | -42.26% | -29.04% | -38.43% | -40.28% |
| ROA | -28.36% | -29.91% | -17.64% | -20.76% | -18.25% |
| 영업이익률 | -57566.15% | -281.22% | -568.14% | -275.30% | -131.39% |
| 순이익률 | -56785.56% | -344.42% | -388.62% | -346.67% | -152.88% |
| 매출총이익률 | — | — | — | — | 41.05% |
| 부채비율 | 25.91% | 54.54% | 69.87% | 111.39% | 161.11% |
| 유동비율 | 938.02% | 133.83% | 388.41% | 149.76% | 110.78% |
| 매출 성장률(YoY) | — | 15952.75% | -46.27% | 38.65% | 80.92% |
| FCF | -366억 | -272억 | -390억 | -167억 | -156억 |
| FCF 마진 | -64522.48% | -298.31% | -795.14% | -245.40% | -126.68% |
| CAPEX/매출 | 20854.57% | 122.68% | 374.31% | 15.31% | 2.15% |
| 항목 | 2021 3Q | 2021 4Q | 2022 1Q | 2022 2Q | 2022 3Q | 2022 4Q | 2023 1Q | 2023 2Q | 2023 3Q | 2023 4Q | 2024 1Q | 2024 2Q | 2024 3Q | 2024 4Q | 2025 1Q | 2025 2Q | 2025 3Q | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -7.63% | -13.31% | -5.42% | -17.22% | -5.71% | -12.72% | -12.16% | -25.67% | -0.25% | 6.27% | -13.21% | -30.35% | -11.75% | 4.82% | -15.52% | -4.75% | -13.90% | -4.94% | -14.09% | -11.23% |
| ROA | -6.07% | -10.25% | -4.20% | -12.24% | -4.31% | -9.00% | -7.92% | -14.78% | -0.14% | 3.81% | -7.26% | -14.30% | -5.29% | 2.60% | -7.65% | -2.16% | -5.90% | -2.24% | -5.64% | -4.50% |
| 영업이익률 | -4518.69% | 8075.48% | -26953.72% | -5703.50% | -77.31% | -227.67% | -4624.23% | -798.27% | -456.82% | -194.55% | -231.74% | -205.20% | -387.68% | -351.45% | -253.79% | -133.74% | -144.80% | -62.65% | -153.83% | -94.81% |
| 순이익률 | -4007.63% | 8929.62% | -17563.05% | -9851.00% | -78.51% | -325.05% | -4211.55% | -1507.67% | -9.61% | 174.02% | -389.98% | -634.40% | -429.45% | 199.17% | -398.27% | -86.36% | -187.02% | -51.79% | -195.26% | -100.55% |
| 매출총이익률 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 30.73% | 37.81% | 35.14% | 51.98% | 19.70% | 43.16% |
| 부채비율 | 21.66% | 25.91% | 26.06% | 36.93% | 38.52% | 54.54% | 88.90% | 131.43% | 139.05% | 69.87% | 72.35% | 97.89% | 113.73% | 111.39% | 156.94% | 161.36% | 188.58% | 161.11% | 182.14% | 179.90% |
| 유동비율 | 2015.39% | 938.02% | 1108.63% | 701.64% | 677.64% | 133.83% | 151.58% | 107.81% | 85.34% | 388.41% | 451.69% | 126.59% | 117.99% | 149.76% | 155.87% | 149.67% | 134.84% | 110.78% | 100.66% | 93.24% |
| 매출 성장률(YoY) | — | — | — | — | 3198.42% | — | 666.63% | 655.66% | -77.37% | -18.82% | 894.97% | 126.04% | -17.42% | -37.21% | 5.76% | 19.52% | 175.77% | 200.09% | 40.07% | 71.33% |
| 순이익 성장률(YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | -28.14% | — | — | — | -178.03% | — | — |
| FCF | -110억 | -140억 | -99.85억 | -80.81억 | 16.06억 | -107억 | -86.76억 | -61.98억 | -182억 | -58.38억 | -64.33억 | -43.48억 | -40.34억 | -18.54억 | -54.22억 | -22.17억 | -47.27억 | -32.01억 | -35.48억 | -42.36억 |
| FCF 마진 | -5991.42% | 10704.47% | -38239.04% | -6312.87% | 26.53% | -369.31% | -4333.87% | -640.71% | -1330.91% | -247.29% | -322.98% | -198.85% | -356.42% | -125.05% | -257.42% | -84.82% | -151.46% | -71.97% | -120.26% | -94.61% |
| CAPEX/매출 | 1061.10% | -6410.94% | 12855.74% | 2682.68% | 9.81% | 130.70% | 1508.28% | 45.52% | 916.60% | 98.02% | 2.00% | 41.14% | 4.64% | 3.25% | 0.38% | 0.38% | 1.59% | 4.43% | 5.63% | 10.45% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 06:17· 연결 · 산식은 항목 툴팁